(Q34601684)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

Drug treatment for multidrug-resistant Acinetobacter baumannii infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

main subject

Acinetobacter baumannii

1 reference

based on heuristic

inferred from title

multiple drug resistance

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Nicola Petrosillo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Laura Ambra Nicolini

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

Matteo Bassetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Silvano Esposito

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

649-660

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

The epidemiology and control of Acinetobacter baumannii in health care facilities

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

The increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Exceptional desiccation tolerance of Acinetobacter radioresistens.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

AcinetobacterOutbreaks, 1977–2000

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Investigation of a multiyear multiple critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii: risk factors and attributable mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

An outbreak of infections with Acinetobacter calcoaceticus in burn patients: contamination of patients' mattresses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Five-year review of infections in a burn intensive care unit: High incidence of Acinetobacter baumannii in a tropical climate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Acinetobacter bacteremia in Hong Kong: prospective study and review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Overview of nosocomial infections caused by gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

The current state of multidrug-resistant gram-negative bacilli in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Antimicrobial resistance of Acinetobacter spp. in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Treatment of Acinetobacter spp infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Transposon-mediated multiple antibiotic resistance in Acinetobacter strains

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Characterization of class 1 integron resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Integration of foreign DNA during natural transformation of Acinetobacter sp. by homology-facilitated illegitimate recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Epidemiological typing and prevalence of integrons in multiresistant Acinetobacter strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

OXA (beta)-lactamases in Acinetobacter: the story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Multidrug-resistant Acinetobacter extremity infections in soldiers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Activities of doripenem (S-4661) against drug-resistant clinical pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Amikacin and colistin for treatment of Acinetobacter baumannii meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Tigecycline: what is it, and where should it be used?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Tigecycline: a new glycylcycline for treatment of serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Rapid development of Acinetobacter baumannii resistance to tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Acinetobacter baumannii infections in a surgical intensive care unit: predictors of multi-drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Evaluation of antibiotic combinations against multidrug-resistant Acinetobacter baumannii using the E-test.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

An outbreak of Acinetobacter baumannii septicemia in a neonatal intensive care unit of a university hospital in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Outcomes of Acinetobacter baumannii infection in critically ill burned patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complex

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Relevance of Digestive Tract Colonization in the Epidemiology of Nosocomial Infections Due to Multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Risk factors, clinical features and outcome ofAcinetobacter bacteremia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.6.649

21 January 2018

Identifiers

DOI

10.2217/17460913.3.6.649

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19072182%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference